ArticleNpj imaging2026
Recording skin oxygenation by dual-wavelength ultra-wideband optoacoustic mesoscopy.
Article in Npj imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Microvascular oxygenation is a key physiological marker implicated in many health conditions, ranging from cardiovascular disease and diabetes to cancer, systemic inflammation, or sepsis, where microvascular-level dysfunction often precedes overt pathology. Ultra-wideband raster-scan optoacoustic mesoscopy (RSOM) offers unprecedented non-invasive visualization of tissue microvasculature, achieving three-dimensional (3D) resolution in the 10-30 micrometer range (axial, lateral). Nevertheless, the lack of availability of suitable multi-wavelength illumination sources has generally limited RSOM to single-wavelength studies of microvasculature morphology. Herein, we present a dual-wavelength ultra-wideband RSOM (DW RSOM) system for dynamic mapping of cutaneous microvascular oxygenation by integrating two diode-pumped solid-state lasers at 515 nm and 532 nm. The system was evaluated on healthy volunteers during post-occlusive reactive hyperemia (PORH) tests on the forearm and proximal nailfold (DRKS00037749 registered on 26th August 2025 on the German Clinical Trials Register). The system recorded 3D oxygenation changes, including ischemic decline, hyperemic overshoot, and recovery, consistent with invasive blood gas analyzer (BGA) measurements. Extracted parameters, such as oxygenation gradients and recovery times, correlated with expected vascular reactivity metrics. These findings validate DW RSOM as a portable prototype for the in vivo assessment of microvascular oxygenation in humans at a single microvessel level. By providing quantitative, layer-resolved imaging of skin microcirculation, DW RSOM offers a promising platform for extending single-wavelength RSOM to studying microvascular dysfunction and supports future clinical translation of optoacoustic technologies toward bedside vascular diagnostics.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.